Neuroblastoma Drug Gets FDA Nod

(MedPage Today) -- WASHINGTON--The FDA granted accelerated approval of the monoclonal antibody naxitamab (Danyelza) plus granulocyte macrophage-colony stimulating factor (GM-CSF) for pediatric and adult patients with certain types of relapsed...